id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-282371-39qo9afy	Khulood, Daulat	Convalescent plasma appears efficacious and safe in COVID-19	2020-09-28		.txt	text/plain	3095	218	52	Convalescent plasma (CP) therapy is a classic adaptive immunotherapy which has been in use for more a century to prevent and treat infections including SARS, Middle East respiratory syndrome (MERS), and H1N1 pandemic. Despite its promising beneficial effects in patients severely ill with COVID-19, CP therapy requires further evaluation in randomized clinical trials (RCTs) as a lack of satisfactory efficacy data from this area certainly enhances the hesitancy with regard to employing this treatment. Although CP therapy showed satisfactory efficacy in treating patients with severe COVID-19, 41 this approach requires evaluation in randomized clinical trials (RCTs) 38 as lack of data from this area certainly enhances the hesitation with regard to employing this treatment. 46 Recently, the FDA has approved use of CP to treat critically ill patients while a clinical trial of plasma therapy for COVID-19 has been approved in the UK. Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection.	./cache/cord-282371-39qo9afy.txt	./txt/cord-282371-39qo9afy.txt